Avalon Pharmaceuticals' Unattributed VC - IV Round

Avalon Pharmaceuticals raised a round of funding on May 22, 2007.

Avalon Pharmaceuticals utilizes the AvalonRx Drug Discovery Engine which uses RNAi gene disruption signatures for the isolation of drugs against previously "intractable" targets. The Engine monitors c…

Articles about Avalon Pharmaceuticals' Unattributed VC - IV Round: